Trial intelligence / Profile preview

GO-PRP: PRP for Knee Osteoarthritis

NCT03082430Unknown

Sponsor
Hôpital Saint Joseph Marseille
Start
Jan 2017
Primary completion
Feb 2018
Modality
Adoptive Cell Transfer
Countries
1
01

Overview

Open-label, single-arm trial of autologous platelet-rich plasma in knee osteoarthritis (OA), sponsored by Hôpital Saint Joseph Marseille. Primary endpoints: Evolution of Pain (VAS/KOOS) at 6 months, Evolution of Knee Function (KOOS) at 6 months and 1 more. Status: unknown.

02

Drugs

autologous platelet-rich plasma
03

Conditions

knee osteoarthritis (OA)

Beyond the preview

Go deeper on NCT03082430.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03082430.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call